Theragen Bio announced that it delivered 4,000 cosmetics worth 125 million won to Pangyo Senior Welfare Center to mark the end of the year.
The cosmetics delivered this time will be delivered to facilities linked to the Pangyo Senior Welfare Center at the end of the year and used to help vulnerable groups in society, including the elderly.
‘Ato Standard’ is a cosmetic product developed by Theragen Bio that contains human umbilical cord blood and highly concentrated exosomes, showing excellent effects on sensitive products and itching.
Taesoon Hwang, CEO of Theragen Bio, said, “We hope that cosmetics that help moisturize and relieve itching in the cold weather will be helpful to the socially vulnerable. We will strive to become an example of ESG management in the bio industry.”
Meanwhile, Theragen Bio is making company-wide efforts in various fields to promote ESG management in the bio industry. In addition to our efforts to fulfill our social responsibilities as an NGS service and new drug development company, we became the first genome company to obtain information security certification (ISO27001) and personal information protection certification (ISO27701) in September 2020, and have maintained certification with excellent scores for three consecutive years. We are also making great efforts to obtain certification related to information protection.
Source: Pangyo Techno Valley Official Newsroom <
→ Go to ‘Asian Innovation Hub Pangyo Techno Valley 2022’ news